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Abstract
Background: Congenital diaphragmatic hernia (CDH) is a congenital malformation associated with life-threatening
pulmonary dysfunction and high neonatal mortality. Outcomes are improved with protective ventilation, less severe
pulmonary pathology, and the proximity of the treating center to the site of delivery. The major CDH treatment center
in Croatia lacks a maternity ward, thus all CDH patients are transferred from local Zagreb hospitals or remote areas
(outborns). In 2000 this center adopted protective ventilation for CDH management. In the present study we assess the
roles of protective ventilation, transport distance, and severity of pulmonary pathology on survival of neonates with CDH.
Methods: The study was divided into Epoch I, (1990–1999, traditional ventilation to achieve normocapnia), and Epoch II,
(2000–2014, protective ventilation with permissive hypercapnia). Patients were categorized by transfer distance (local
hospital or remote locations) and by acuity of respiratory distress after delivery (early presentation-occurring at birth, or
late presentation, ≥6 h after delivery). Survival between epochs, types of transfers, and acuity of presentation
were assessed. An additional analysis was assessed for the potential association between survival and end-capillary
blood CO2 (PcCO2), an indirect measure of pulmonary pathology.
Results: There were 83 neonates, 26 in Epoch I, and 57 in Epoch II. In Epoch I 11 patients (42 %) survived, and in Epoch
II 38 (67 %) (P = 0.039). Survival with early presentation (N = 63) was 48 % and with late presentation 95 % (P <0.001).
Among early presentation, survival was higher in Epoch II vs. Epoch I (57 % vs. 26 %, P = 0.031). From multiple logistic
regression analysis restricted to neonates with early presentation and adjusting for severity of disease, survival
was improved in Epoch II (OR 4.8, 95%CI 1.3–18.0, P = 0.019). Survival was unrelated to distance of transfer
but improved with lower partial pressure of PcCO2 on admission (OR 1.16, 95%CI 1.01–1.33 per 5 mmHg decrease,
P = 0.031).
Conclusions: The introduction of protective ventilation was associated with improved survival in neonates with
early presentation. Survival did not differ between local and remote transfers, but primarily depended on severity
of pulmonary pathology as inferred from admission capillary PcCO2.
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Background
Congenital diaphragmatic hernia (CDH) is a congenital
malformation associated with life-threatening pulmonary
dysfunction and high neonatal mortality. In neonates
with CDH the presence of respiratory distress after
delivery indicates severe pulmonary involvement that
requires medical management which includes mech-
anical ventilatory support prior to undergoing surgical
correction [1].
The University Hospital Center (UHC) in Zagreb
Croatia is the national treatment center for neonates
with CDH. Before 2000, neonates with CDH cared for
at UHC underwent intermittent mandatory ventilation
(IMV) to achieve hyperventilation, a strategy based
on the premise that respiratory alkalosis may help control
degree of pulmonary hypertension [1–3]. However,
ventilation of hypoplastic lungs with high tidal vol-
umes may induce volutrauma associated with intra-
alveolar hemorrhage and interstitial pulmonary edema
[4–6]. It was subsequently determined that protective
ventilation which uses the minimal pressure and vol-
ume settings to achieve acceptable oxygenation while
allowing for hypercapnia can reduce lung injury [7–11].
Therefore, in the year 2000 UHC adopted protective ven-
tilation for neonates with CDH.
The UHC lacks a maternity ward, thus all neonates
with CDH are either transferred from local Zagreb
hospitals or remote areas in Croatia. This practice is
concerning because remote transfer of CDH neonates
may increase mortality [12]. The primary aim of this
study was to estimate the effects of the introduction
of protective ventilation on survival. A secondary aim
was to examine whether remote transfer, compared to
local transfer, impacted survival.
Methods
This study was approved by the Institutional Ethics
Committee of the University Hospital Centre (UHC),
Zagreb, Croatia. Due to retrospective design of this
study the written consent was waived by the UHC In-
stitutional Ethics Committee.
Study design
A retrospective cohort study of neonates with CDH born
between January 1, 1990 and December 31, 2014 who
were treated at a single institution. The primary aim was
to assess whether the survival of neonates with CDH im-
proved after the year 2000 with the introduction of pro-
tective ventilatory strategy. Since neonates with early
presentation are expected to have lower survival, the ef-
fects of protective ventilation both overall and in the
subset of neonates with early presentation was assessed.
The secondary aim was to explore the association be-
tween the type of transfer (local vs. remote) and
survival. Because the time period covered by conventional
ventilatory strategies was characterized by a national con-
flict (Croatian War of Independence 1991–1995) and trav-
elling was hampered, this association was explored
following the introduction of protective ventilation.
Study setting
The neonatal intensive care unit (NICU) of University
Hospital Center, Zagreb Croatia. The UHC is the na-
tional treatment center for neonates with CDH. UHC
lacks a maternity ward; therefore all subjects in this
study are outborns.
Definitions
Epoch I is the period between January 1, 1990 and
December 31, 1999, during which time hyperventila-
tion with non-synchronized ventilation was used. Epoch II
is the period between January 1, 2000, and December 31,
2014, during which time a permissive hypercapnia using
protective ventilation was used. Outborn status refers to
infants born in another hospital requiring transport to
higher level of care. Patients were defined as “local
transfers” if they came from local Zagreb hospitals or
“remote transfers” from the rest of the country. Early
presentation is when respiratory distress is evident im-
mediately after delivery requiring endotracheal intub-
ation and mechanical ventilation. Late presentation, on
the other hand, is when the onset of breathing difficul-
ties is delayed >6 h after delivery.
Management strategies
Epoch I
Neonates were sedated, paralyzed, and ventilated with
intermittent mandatory ventilation (IMV) to achieve re-
spiratory alkalosis and postductal oxyhemoglobin satur-
ation above 90 % to ameliorate pulmonary hypertension.
This strategy often required higher peak inspiratory
pressures (PIP), respiratory rates and oxygen concen-
trations. In those with available records of PIP, the
values were between 30 and 40 cmH2O.(new line and
header) Epoch II (new line) Ventilation was protoco-
lized, and all neonates received protective ventilation
aimed to minimize volutrauma with the use of min-
imal pressure and volume settings and inspired oxygen
concentration to achieve acceptable preductal oxygenation
saturations (≥85 %) while permitting hypercapnia (≤65
mmHg). Only two modes of ventilation were used during
this time period: assist-control plus volume limit mode
(A/C + VL) and pressure support ventilation with volume
guarantee mode (PSV + VG). Both modes fully sup-
ported synchronized ventilation aided by controlled
“demand flow” circuitry which synchronizes inspiratory
gas delivery close to the breathing pattern of the neo-
nate. Ventilatory settings were set per protocol. In the
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A/C + VL mode the tidal volume limit was 6 mL/kg,
PEEP of 2–3 cm H2O, PIP ≤ 25 cmH2O, and the
backup respiratory rate 40 per min. If respiratory acid-
osis (obtained from preductal capillary blood) was
present (pH <7.25, PcCO2 >65 mmHg), ventilatory set-
tings were changed by increasing PIP by 2 cmH2O
(until maximum PIP of 25 cmH2O was achieved). In
patients ventilated with PSV + VG mode the mean VG
used was 4.0 mL/kg (range 2.6–5.5 mL/kg), PEEP 3.8
(range 2.5–5) cm H2O, PIP ≤ 25 cmH2O, and backup
respiratory rate 40/min. If severe respiratory acidosis
was present, VG was increased to a maximum 5.5 mL/kg
exceeding the PIP limit if needed. With this strategy
sedation and muscle paralysis were infrequently used
and only in newborns with patient-ventilator asyn-
chrony. High frequency oscillation ventilation (HFOV)
was a rescue treatment for neonates who continued to
have hypoxia and hypercarbia (PcCO2 >65 mmHg) des-
pite optimization of either ventilatory mode. During
Epoch II inhaled nitric oxide (iNO) became available
and was used for neonates with ductal shunting (differ-
ence between preductal and postductal oxygen satur-
ation >5 %), refractory preductal hypoxemia (PcO2 <60
mmHg with FiO2 >80 %), and for elevated right ven-
tricular pressures. Surgical repair was typically done
following initial optimization of respiratory parameters.
Data collection
Patient variables that were abstracted included demo-
graphic information (date of birth, sex, place of birth
[local vs. remote transfers]); birth information (gesta-
tional age, birth weight, Apgar scores); CDH information
(prenatal diagnosis, acuity of presentation, pulmonary
hypertension, type of CDH, presence of peritoneal sac
and diaphragmatic aplasia), and physiologic variables
obtained early during hospitalization (admission preductal
capillary blood gases, lowest body temperature and lowest
mean blood pressure within 12 h of admission). Probabil-
ity of survival (POS) was assessed from the equation
proposed by the Congenital Diaphragmatic Hernia
Study Group [13], to categorize neonates into 3 POS
score groups based on birth weight and 5-min Apgar
score: low (0 %–33 %), moderate (34 %–66 %), and high
(67 %–100 %) predicted survival groups. Variables re-
garding CDH management abstracted included mech-
anical ventilation mode; occurrence of preoperative
pneumothorax; use of iNO, surfactant, and/or vaso-
active support; type of surgical repair (primary vs. non-
primary with patch); and time between delivery and
surgery. Survival to hospital discharge was noted.
Statistical analysis
Data are presented using mean ± SD or median
[25th, 75th percentile] for continuous variables, and
frequency percentages for categorical variables. Char-
acteristics were compared between groups using the
2- sample t-test, rank sum test, Chi square test, or
Fisher’s exact test. Logistic regression was used to as-
sess whether hospital survival was associated with
epoch after adjusting for POS score. In order to
assess for trends in survival over time, before and
after the introduction of the protective ventilation,
logistic regression analyses was performed for each
time period with hospital survival as the dependent
variable and calendar year as the continuous explana-
tory variable. To explore the association between
local vs. remote transfer on survival we focused on
neonates with early presentation of symptoms during
Epoch II. Survival was compared using the Chi
square test. In all cases 2-tailed P values <0.05 were
considered statistically significant. Data were analyzed
using SAS version 9.3 (SAS Institute Inc, Cary, NC).
Results
Between January 1, 1990, and December 31, 2014,
there were 83 neonates who received formal intensive
care treatment, 26 were treated in Epoch I, and 57 in
Epoch II. Sixteen additional patients were excluded
for various reasons (see Fig. 1). All neonatal transfers
to our medical center were accomplished by ground
ambulance. Ventilation during transfer was accom-
plished via hand-held self-inflating bags for all neo-
nates in Epoch I, and for the majority of neonates in
Epoch II. In Epoch II, 9 neonates, 1 local (survived)
and 8 remote (3 died) transfers, received ventilation
through a pressure controlled ventilator integrated in
transport incubator.
Table 1 summarizes demographic and disease char-
acteristics of neonates with CDH. Table 2 summarizes
admission capillary blood gases and vital signs within
12 h of admission. Table 3 summarizes medical and
surgical interventions. During Epoch I all neonates re-
ceived IMV, while in Epoch II protective ventilation
was utilized, including 8 patients who received rescue
HFOV. Surfactant and vasoactive support increased
and iNO became available during Epoch II.
Overall cohort survival
In Epoch I 11 of 26 patients (42 %) survived to discharge,
compared to 38 of 57 (67 %) in Epoch II (OR = 2.7, 95 %
CI 1.1 to 7.1, P = 0.039 for survival during Epoch II vs.
Epoch I). The percentage of patients who died after being
admitted without surgery was similar between Epochs I
and II, 27 % vs. 21 %, respectively (P = 0.815). Among
those who were discharged, length of stay did not differ
significantly between Epoch I vs. Epoch II (37 [19, 55] vs.
34 [23, 67] days; rank sum test P = 0.615). Calculated POS
score negatively correlated with admission end-capillary
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partial pressure of carbon dioxide, PcCO2 (r = −0.35,
P = 0.008). Survival was similar for patients who were
local vs. remote transfers, (53 % vs. 67 %, P = 0.216).
No temporal trends in survival were observed over
calendar time during Epoch I (P = 0.490) or Epoch II
(P = 0.373). From an analysis restricted to Epoch II,
there was no difference in survival between neonates
who were prenatally diagnosed with CDH compared
to those without prenatal diagnosis (P = 0.174).
Early vs. late presentation survival
Sixty-three neonates had early presentation and their
survival was worse compared to those with late presen-
tation (48 % vs. 95 % survival, P <0.001). Among early
presentation neonates, survival was higher in Epoch II
vs. Epoch I (25 of 44, 57 % vs. 5 of 19, 26 %, OR 3.7 95 %
CI 1.1–12.0, P = 0.031). From multiple logistic regres-
sion analysis restricted to early presentation neonates
and adjusting for POS score, survival improved in
Epoch II compared to Epoch I (OR 4.8, 95 % CI 1.3–
18.0, P = 0.019). In an analysis restricted to neonates
with early presentation, no temporal trends were observed
over calendar time during Epoch I (P = 0.304) or Epoch
II (P = 0.777). Figure 2 shows hospital survival in neo-
nates with early presentation of respiratory distress for
Epoch I and II according to expected survival based on
POS score. Within each expected survival category, ob-
served survival was higher during Epoch II.
Fig. 1 Patients with congenital diaphragmatic hernia. Exclusions: other types of congenital diaphragmal hernia (n = 4): Morgagni hernia,
paraesophageal hernia, central hernia, severe diaphragmatic eventration. Lethal anomaly (n = 1) Edwards syndrome (trisomy 18) *Early presentation is
defined as respiratory distress immediately after birth requiring endotracheal intubation; †Late presentation is defined as respiratory distress
either absent or present >6 h after delivery
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Local vs. remote transfer survival
During Epoch II, 44 neonates had early presentation, 31
were local, and 13 were remote transfers. All local
transfers, 31 of 31 (100 %), and 11 of 13 (85 %) remote
transfers were admitted within 24 h after delivery. Two
remote transfers arrived after 24 h from a distant
(280 km) hospital via ground ambulance. Of the re-
mote transfers 9 (69 %) survived hospitalization com-
pared to 16 (52 %) of local transfers (P = 0.282).
Birth characteristics did not differ between local and
Table 1 Demographic and disease characteristics in children with congenital diaphragmatic hernia (CDH)
Characteristic Overall Epoch I Epoch II P-value
(N = 83) (N = 26) (N = 57)
Prenatal diagnosis of CDHa 21 (25) 1 (4) 20 (35) <0.001
Sex 0.888
Male 52 (63) 16 (62) 36 (63)
Female 31 (37) 10 (38) 21 (37)
Gestational age, weeks 38.6 ± 2.5 39.0 ± 2.0 38.4 ± 2.7 0.318
Birth weight, kg 3.1 ± 0.6 3.1 ± 0.6 3.1 ± 0.6 0.909
Small for gestational age 4 (5) 1 (4) 3 (5) 1.00
Apgar 1 minute 6.4 ± 2.8 7.1 ± 2.6 6.1 ± 2.9 0.129
Apgar 5 minute 6.5 ± 2.7 6.5 ± 2.8 6.5 ± 2.7 0.920
Early presentationb 63 (76) 19 (73) 44 (77) 0.684
Local transfers 47 (57) 10 (38) 37 (65) b 0.024
CDH type 0.661
Left 70 (84) 21 (81) 49 (86)
Right 12 (15) 5 (19) 7 (12)
Bilateral 1 (1) 0 (0) 1 (2)
Probability of survival score (%) 0.63 ± 0.26 0.63 ± 0.24 0.63 ± 0.26 0.988
High (67–100) 43 (52) 14 (54) 29 (51)
Moderate (34–66) 29 (35) 9 (35) 20 (35)
Low (0–33) 11 (13) 3 (11) 8 (14)
Pneumothorax (preoperative) 13 (16) 4 (15) 9 (16) 0.962
Pulmonary hypertension <0.001
Not assessed 20 (24) 20 (77) 0 (0)
Present 33 (40) 1 (4) 32 (56)
Absent 30 (36) 5 (19) 25 (44)
Diaphragmal aplasia 7 (8) 3 (11) 4 (7) 0.672
Peritoneal sac present 8 (10) 3 (11) 5 (9) 0.701
Data are N (%) or mean ± SD
aAll prenatally diagnosed CDH from remote areas were transferred to Zagreb, 1 in Epoch I, and 15 in Epoch II
bRespiratory distress at birth
Table 2 Admission capillary blood gases, lowest mean blood pressure and lowest temperature over the first 12 h after admission
Characteristic Epoch I Epoch II P-Value
N Mean ± SD N Mean ± SD
PcO2, mmHg 21 55.8 ± 25.0 57 52.3 ± 19.5 0.521
PcCO2, mmHg 20 57.3 ± 19.3 57 70.4 ± 30.9 0.080
pH 22 7.17 ± 0.19 54 7.16 ± 0.22 0.831
Base deficit, mEq/L 20 −5.82 ± 6.39 54 −5.95 ± 7.43 0.946
Lowest temperature, °C 19 36.3 ± 0.4 51 36.1 ± 0.6 0.228
Lowest mean blood pressure, mmHg 19 42.0 ± 7.6 56 38.4 ± 8.1 0.094
Abbreviation: PcCO2 partial pressure of carbon dioxide in the end-capillary blood
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remote transfers, including gestational age (38.2 ± 2.7
vs. 38.4 ± 3.0 weeks, P = 0.900), birth weight (3.1 ± 0.7 vs.
2.9 ± 0.6 kg, P = 0.356), Apgar scores at 5 min (6.0 ± 2.2
vs. 4.9 ± 2.7, P = 0.193), and POS score (0.60 ± 0.23 vs.
0.46 ± 0.30, P = 0.113). However, on admission, local
transfers had lower pH (7.01 ± 0.19 vs. 7.26 ± 0.12, P
<0.001), lower base deficit (−9.8 ± 7.9 mq/L vs. -1.6 ± 4.1
mq/L, P = 0.001), and higher PcCO2 (87.5 ± 30.1 mmHg
vs. 59.8 ± 16.4 mmHg, P = 0.003) compared to remote
transfers. Also lowest mean blood pressure during the first
12 h after admission was significantly lower in local trans-
fers (34.4 ± 7.2 mmHg vs. 41.2 ± 5.7 mmHg, P = 0.005) as
was the lowest body temperature (35.8 ± 0.7 °C vs. 36.5 ±
0.5 °C, P = 0.002). From a multivariable logistic regression
analysis that adjusted for PcCO2, survival was not found to
be significantly associated with the type of transfer (local
Table 3 Interventions and type of surgical repair in neonates with congenital diaphragmatic hernia
Characteristic Epoch I Epoch II P-value
(N = 26) (N = 57)
Primary mechanical ventilation, n (%) <0.001
Intermittent mandatory ventilation 26 (100) 0 (0)
Assist-control + volume limit mode 0 (0) 26 (45)
Pressure support + volume guarantee mode 0 (0) 31 (55)
High frequency oscillatory ventilationa 0 (0) 8 (15) ——
Inhaled nitric oxide 0 (0) 31 (54) <0.001
Surfactant administration 1 (4) 16 (28) <0.001
Vasoactive support 13 (50) 55 (96) <0.001
Died before surgery 7 (27) 12 (21) 0.815
Time between delivery and surgery, hoursb 24.5 [24.7, 28.2] 29 [23.0, 29.0] 0.550
Type of surgical repair 19 (73) 45 (79) 0.815
Primary closure 18 39
Patch repair 1 5
Muscle flap repair 0 1
All values are N (%) or median [25th, 75th percentile]
aUsed only as a rescue technique
bAlthough current practice shifted from emergent repair of CDH to a policy of preoperative medical stabilization using a variety of intensive care management
strategies, a recent Cochrane analysis showed that there was no clear evidence which favors delayed versus immediate (within 24 h of birth) surgical
intervention [29]
Fig. 2 Hospital survival in neonates with early presentation of respiratory distress for Epoch I and II according to expected survival (low, moderate and
high) based on calculated probability of survival score (see Methods). Within each risk stratification group there was a large increase in survival in Epoch II
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vs. remote, P = 0.997). However, survival significantly im-
proved with lower admission PcCO2 (OR 1.16, 95 % CI
1.01–1.33 per 5 mmHg decrease, P = 0.031).
Discussion
The main finding of this study is that protective ven-
tilation for newborns with CDH was associated with
improvement in hospital survival, primarily due to a
substantial increase in survival among high-risk neo-
nates. Despite higher acuity of CDH disease in local
neonates compared to remote transfers, the survival was
comparable, reflecting high level of care they have re-
ceived. The level of admission capillary PcCO2 was an ex-
cellent marker for prognostication of survival.
The two most important management changes be-
tween epochs were the introduction of protective ven-
tilation and iNO. While iNO is an effective method
to control pulmonary hypertension, its use may not re-
duce CDH mortality [14]. In contrast, ventilator-induced
lung injury may substantially increase mortality in neo-
nates with hypoplastic lungs [3, 6–8, 10, 15] while protect-
ive ventilation improves survival, and may minimize the
need for extracorporeal membrane oxygenation (ECMO)
[11]. However, not all studies reported improvement in
survival with ECMO [6, 16], and neonatal ECMO was un-
available in Croatia during the study timeframe. In our
study the adoption of protective ventilation was associated
with a substantial improvement in survival for high-risk
neonates with respiratory distress occurring immediately
after delivery. Our overall survival in Epoch II was 67 %,
which is within the range reported by others [17–21].
However, the true CDH mortality is likely to be higher, as
this report does not include “hidden mortality”, i.e. new-
borns who died before they reached the neonatal unit [22,
23]. A large study reported that 35 % of live-born infants
died before being transported to the higher level of care
and the population of infants reaching tertiary surgical
centers represents approximately 40 % of the total number
of cases with CDH [24].
The effect of transport on survival in children with
CDH is difficult to assess because of multiple confounders
which may introduce patient selection bias. Some studies
report higher mortality for outborns (potential bias: more
severe cases were transferred and therefore less likely to
survive) [12, 25], while others describe lower mortality of
outborns (potential bias: transferred only less severe cases
and therefore more likely to survive) [26, 27]. In the
present study, there was no difference in survival between
local and remote transfers, but these findings also reflect
probable referral bias secondary to the availability of re-
sources to transport high acuity neonates and transport
distance. We speculate that because of the difficulties in
long-distance transfers in Croatia (i.e., use of ground am-
bulance rather than helicopter) the transfer of CDH
newborns from remote locations was reserved for less se-
vere cases, introducing a potential bias towards improved
survival. This speculation is supported by our observation
that local neonates had more severe derangements in vital
signs and had more severe lung hypoplasia as inferred
from higher capillary PcCO2. Arterial PaCO2 is a good
marker for the degree of hypoplastic lung disease. Salas et
al. [28] demonstrated that PaCO2 >88 mmHg on admis-
sion (which was the mean PcCO2 of our local transfers)
was associated with low survival, while PaCO2 <66 mmHg
on admission (which was the mean PcCO2 of our remote
transfers) was a marker of improved survival. Our finding
of comparable survival between “sicker” local referrals and
remote transfers suggests that even the sickest neonates
who succeed to reach tertiary care may achieve substantial
survival. Since we encountered this imbalance of disease
severity between remote and local transfers, our study is
limited in drawing definitive conclusions regarding the ef-
fect of transport per se on survival in neonates with CDH.
Limitations
The limitation of our retrospective study is possibility for
presence of unforeseen confounders. Furthermore, the long
time span of the study may hide other unaccounted practice
changes that occur over calendar time. In order to examine
the effect of calendar time on outcomes additional analyses
were done that showed that hospital survival did not increase
or decrease over time within either epoch, and the improve-
ment of survival after year 2000 suggests that improved sur-
vival can likely be attributed to protective ventilation.
Conclusions
With the introduction of protective ventilation, survival for
high-risk neonates with early respiratory distress substan-
tially improved. Better survival was associated with lower
admission capillary PcCO2. Admission blood gases and vital
signs were substantially better in remote transfers indicat-
ing on potential referral bias related to transferring neo-
nates with less severe disease. After adjusting for admission
PcCO2, survival did not differ significantly between local
and remote transfers. This suggests that being delivered
close to a tertiary care facility may be advantageous, espe-
cially for neonates with high disease acuity. Therefore,
mothers living in remote rural areas with less specialized
neonatal care should be considered for prenatal screening,
and if CDH is detected they should be referred for delivery
close to an institution with specialized neonatal care.
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